Skip to main content

Table 1 Pulmonary myeloperoxidase, cytokine and chemokine levels 48 and 96 hours after induction of lethal H1N1 influenza A infection

From: Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study

 

Placebo

rm-APC

placebo

rm-APC

MPO (ng/ml)

5.0 (3.9 to 5.9)

4.9 (4.2 to 5.1)

6.4 (5.6 to 6.9)

6.8 (6.2 to 8.9)

TNF-α (pg/ml)

120 (97 to 134)

121 (101 to 143)

393 (293 to 495)

167 (139 to 344) *

IL-1β (pg/ml)

236 (100 to 415)

389 (331 to 389)

479 (444 to 549)

371 (345 to 587)

IL-6 (ng/ml)

0.9 (0.7 to 1.0)

0.8 (0.7 to 0.9)

1.3 (1.0 to 1.6)

1.0 (0.7 to 1.3)

IL-12 (pg/ml)

B.D.

B.D.

54 (37 to 64)

11 (5.0 to 28) *

IL-10 (pg/ml)

137 (86 to 165)

131 (101 to 153)

115 (82 to 175)

65 (23 to 147)

IFN-γ (pg/ml)

6.8 (6.0 to 9.7)

6.9 (5.8 to 7.9)

6.7 (4.9 to 8.1)

5.6 (3.5 to 7.9)

KC (ng/ml)

3.1 (2.3 to 3.7)

4.0 (2.9 to 5.1)

3.4 (2.6 to 4.4)

4.2 (3.3 to 5.6)

MIP-2 (ng/ml)

1.2 (0.8 to 1.4)

1.5 (1.2 to 1.6)

1.4 (1.3 to 1.5)

1.5 (1.4 to 1.7)

  1. Data are medians (interquartile ranges) of eight mice per group at each time point. * indicates statistical significance compared to placebo (P < 0.05). MPO, myeloperoxidase, TNF-α, tumor necrosis factor-α, IL, interleukin, IFN-γ, interferon-γ, KC, keratinocyte-derived chemokine, MIP-2, macrophage inflammatory protein-2, B.D., below detection.